Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis

BACKGROUND: US Food and Drug Administration (FDA) regulations state that any prescription drug promotion that presents drug benefits to consumers must also disclose certain information about the drug’s risks in a similar manner. Nearly three-quarters of all US mobile phone subscribers use a smartpho...

Descripción completa

Detalles Bibliográficos
Autores principales: Aikin, Kathryn J, Sullivan, Helen W, Dolina, Suzanne, Lynch, Molly, Squiers, Linda B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516101/
https://www.ncbi.nlm.nih.gov/pubmed/28676469
http://dx.doi.org/10.2196/jmir.7306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516101/
https://www.ncbi.nlm.nih.gov/pubmed/28676469
http://dx.doi.org/10.2196/jmir.7306

Ejemplares similares